Display options
Cite
Mahzounieh M, Ghorani M, Karimi A, et al. Prevalence of Human T-Lymphotropic Virus Types I and II in Patients With Hematological Disorders in Isfahan, Iran. Jundishapur J Microbiol. 2015;8(6):e17201doi: 10.5812/jjm.8(5)2015.17201.
Mahzounieh, M., Ghorani, M., Karimi, A., Pourgheysari, B., & Nikoozad, R. (2015). Prevalence of Human T-Lymphotropic Virus Types I and II in Patients With Hematological Disorders in Isfahan, Iran. Jundishapur journal of microbiology, 8(6), e17201. https://doi.org/10.5812/jjm.8(5)2015.17201
Mahzounieh, Mohammadreza, et al. "Prevalence of Human T-Lymphotropic Virus Types I and II in Patients With Hematological Disorders in Isfahan, Iran." Jundishapur journal of microbiology vol. 8,6 (2015): e17201. doi: https://doi.org/10.5812/jjm.8(5)2015.17201
Mahzounieh M, Ghorani M, Karimi A, Pourgheysari B, Nikoozad R. Prevalence of Human T-Lymphotropic Virus Types I and II in Patients With Hematological Disorders in Isfahan, Iran. Jundishapur J Microbiol. 2015 Jun 25;8(6):e17201. doi: 10.5812/jjm.8(5)2015.17201. eCollection 2015 Jun. PMID: 26301057; PMCID: PMC4539791.
Copy Download .nbib Format: NLM
Share it on

Jundishapur J Microbiol. 2015 Jun 25;8(6):e17201. doi: 10.5812/jjm.8(5)2015.17201. eCollection 2015 Jun.

Prevalence of Human T-Lymphotropic Virus Types I and II in Patients With Hematological Disorders in Isfahan, Iran.

Jundishapur journal of microbiology

Mohammadreza Mahzounieh, Mohammadreza Ghorani, Ali Karimi, Batoul Pourgheysari, Razieh Nikoozad

Affiliations

  1. Pathobiology Department, Research Institute of Zoonotic Diseases, Shahrekord University, Shahrekord, IR Iran.
  2. Department of Microbiology, Tehran University, Tehran, IR Iran.
  3. Microbiology and Immunology Department, Shahrekord University of Medical Sciences, Shahrekord, IR Iran.
  4. Pathology and Hematology Department, Shahrekord University of Medical Sciences, Shahrekord, IR Iran.
  5. Department of Microbiology, Islamic Azad University, Falavarjan Branch, Falavarjan, IR Iran.

PMID: 26301057 PMCID: PMC4539791 DOI: 10.5812/jjm.8(5)2015.17201

Abstract

BACKGROUND: Human T-cell lymphotropic virus types Ι and ΙΙ (HTLV-Ι and HTLV-II) are deltaretroviruses which may cause leukemia, lymphoma and HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP). In addition, HTLV-1 may be related to thalassemia and hemophilia cases after blood transfusion.

OBJECTIVES: The aim of this study was evaluation of the prevalence of HTLVs in patients with hematological disorders (leukemia, thalassemia, lymphoma and hemophilia).

PATIENTS AND METHODS: This cross-sectional study was conducted during April to October 2012. A total of 101 serum samples were collected from patients and were stored at -20ºC. DNA was extracted from serum by an extraction kit. The extracted DNA was tested by polymerase chain reaction (PCR) for detection of HTLV-Ι and HTLV-II pol and tax gene sequences, respectively. Samples were collected from 67 (66.33%), 20 (19.80%), 4 (3.96%), and 10 (9.90%) patients with thalassemia, leukemia, lymphoma and hemophilia, respectively.

RESULTS: One thalassemia sample was HTLV-Ι positive, but none of the samples contained the genome of HTLV-II. The prevalence of HTLV-Ι in this study in patients with hematological disorders was 0.99%.

CONCLUSIONS: The prevalence of HTLV-Ι in hematological disorders was similar to that of other parts of Iran. The present study revealed that HTLV-Ι screening should be performed before blood transfusion to reduce the risk of virus transmission in patients with hematological disorders. More study should be performed to detect these viruses in blood donors.

Keywords: Hematological Diseases; Human T-lymphotropic Virus; Iran

References

  1. J Med Assoc Thai. 1993 Oct;76 Suppl 2:103-5 - PubMed
  2. Int J Exp Pathol. 2001 Jun;82(3):135-47 - PubMed
  3. Commun Dis Public Health. 2004 Sep;7(3):207-11 - PubMed
  4. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jul 1;15(3):238-42 - PubMed
  5. Int J Hematol. 2002 Jan;75(1):78-84 - PubMed
  6. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9 - PubMed
  7. Lancet. 1987 Mar 14;1(8533):596-9 - PubMed
  8. J Virol Methods. 2002 Apr;102(1-2):37-51 - PubMed
  9. Rev Inst Med Trop Sao Paulo. 1993 May-Jun;35(3):271-3 - PubMed
  10. AIDS Res Hum Retroviruses. 2012 Sep;28(9):1095-1101 - PubMed
  11. Ann Intern Med. 1989 Oct 1;111(7):555-60 - PubMed
  12. Pathology. 2009;41(5):498-9 - PubMed
  13. J Virol. 1981 Jun;38(3):906-15 - PubMed
  14. J Med Virol. 2011 Apr;83(4):745-8 - PubMed
  15. Nat Rev Cancer. 2007 Apr;7(4):270-80 - PubMed
  16. Iran J Allergy Asthma Immunol. 2006 Dec;5(4):153-66 - PubMed
  17. Annu Rev Immunol. 1997;15:15-37 - PubMed
  18. J Clin Virol. 2011 Nov;52(3):172-6 - PubMed
  19. Am J Hematol. 2004 Dec;77(4):336-9 - PubMed
  20. Saudi J Kidney Dis Transpl. 2008 Sep;19(5):838-41 - PubMed
  21. Leuk Lymphoma. 2008 Feb;49(2):315-21 - PubMed
  22. Int J Cancer. 1992 Jul 30;51(6):886-91 - PubMed
  23. Oncogene. 2005 Sep 5;24(39):6058-68 - PubMed
  24. AIDS Res Hum Retroviruses. 1993 Sep;9(9):869-74 - PubMed
  25. Commun Dis Public Health. 2004 Sep;7(3):200-6 - PubMed

Publication Types